Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Synovial × Epirubicin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Triple Negative Breast Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 2 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Inflammatory Breast Neoplasms 1 HR+/HER2- Breast Cancer 1 Epstein-Barr Virus Infections 1 Congenital Abnormalities 1 Carcinoma, Adenoid Cystic 1 CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

Cyclophosphamide 6 fludarabine 4 tazemetostat 2 pembrolizumab 2 Doxorubicin 2 tremelimumab 1 sotigalimab 1 pazopanib 1 fludarabine phosphate 1 durvalumab 1 anlotinib 1 aldesleukin 1 Zoledronic Acid 1 X-Rays 1 Trabectedin 1 Tablets 1 Specimen Handling 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Quality of Life 1 Phantoms, Imaging 1 Midazolam 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Interleukin-2 1 Immunotherapy, Adoptive 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Digoxin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡